Loading...
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
Background. Anti-PD1/PDL1 immune checkpoint inhibitors (ICIs) showed promising results in breast cancer, and exploration of additional actionable immune checkpoints is ongoing. Inflammatory breast cancer (IBC) is an aggressive form of disease, the immune tumor microenvironment (TME) of which is poor...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8158040/ https://ncbi.nlm.nih.gov/pubmed/34104544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1929724 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|